Pre-existing humoral immunity and CD4(+) T cell response correlate with cross-reactivity against SARS-CoV-2 Omicron subvariants after heterologous prime-boost vaccination

BACKGROUND: Information regarding the heterologous prime-boost COVID vaccination has been fully elucidated. The study aimed to evaluate both humoral, cellular immunity and cross-reactivity against variants after heterologous vaccination. METHODS: We recruited healthcare workers previously primed wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ching-Fen, Fu, Yi-Chen, Ho, Tzong-Shiann, Chen, Po-Lin, Lee, Nan-Yao, Tsai, Bo-Yang, Tsai, Pei-Jane, Ko, Wen-Chien, Liu, Ching-Chuan, Cheng, Chao-Min, Shieh, Chi-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124102/
https://www.ncbi.nlm.nih.gov/pubmed/37100338
http://dx.doi.org/10.1016/j.clim.2023.109342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124102/
https://www.ncbi.nlm.nih.gov/pubmed/37100338
http://dx.doi.org/10.1016/j.clim.2023.109342

Ejemplares similares